Our study indicated that quercetin, glabridin, and gallic acid, three potential compounds for the treatment of COVID-19, may decrease the expression of ACE2 via regulation of TFs or miRNAs of ACE2 and subsequently exert an antiviral effect. Here, ACE2 is linked to COVID-19.